Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
暂无分享，去创建一个
S. Digumarthy | B. Little | F. Fintelmann | J. Gainor | M. Petranović | Kevin B Huang | S. McDermott | S. Mercaldo | A. Graur